Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Comment by CancerSlayeron Jul 14, 2021 4:20pm
146 Views
Post# 33543999

RE:RE:Bandits $$$$$

RE:RE:Bandits $$$$$We can thank Brad for most of the misery.  Wish the company would be more responsible & quickly give up on their near-term Nasdaq listing intentions...at this rate, they're going to need a ridiculous 1:12+ reverse split.  If they actually care about "all" shareholders, I'd advise they use a more steady/longer term approach & actually establish a reliable rev stream +/- have a pending utility patent (not provisional).  Just reading the tea leaves & seeing troubles ahead with this plummeting sp....& nothing more than a lot of impatient/irrational decision-making from a retail investor perspective...guess that should be no big surprise.  Also noted that Dr. Sanderson just recently resigned from the BoD = loss of another scientific/objective opinion.   What a miserable experience it has been for all retail investors.  All of the above...JMHO.
<< Previous
Bullboard Posts
Next >>